Calcium signaling is a central mechanism for numerous cellular functions and particularly relevant for immune cell proliferation. However, the role of calcium influx in mitotic cell cycle progression is largely unknown. We here report that proliferating rat mast cells RBL-2H3 tightly control their major store-operated calcium influx pathway, I CRAC , during cell cycle progression. While I CRAC is maintained at control levels during the first gap phase (G1), the current is significantly up-regulated in preparation for and during chromatin duplication. However, mitosis strongly suppresses I CRAC . Non-proliferating cells deprived of growth hormones strongly down-regulate I CRAC while increasing cell volume. We further show that the other known calcium (and magnesium) influx pathway in mast cells, the TRPM7-like magnesium-nucleotide-regulated metal (MagNuM) current, is largely uncoupled from cell cycle regulation except in G1. Taken together, our results demonstrate that both store-operated calcium influx via I CRAC and MagNuM are regulated at crucial checkpoints during cell cycle progression.
Introduction
Cell growth and division is a fundamental, tightly controlled process in the cell's life, whose deregulation can lead to pathological conditions [1] . A proliferating cell passes through an orderly sequence of phases that comprise the mitotic cell cycle: (i) gap phase 1 (G1), where cell mass grows and the cell prepares to synthesize DNA; (ii) synthesis phase (S), during which DNA synthesis occurs, duplicating the cell's genome; (iii) gap phase 2 (G2), in which DNA repair and protein synthesis prepare the cell's division; (iv) mitotic phase (M), in which division of the cell into two daughter cells takes place (cytokinesis) [2] . As the cell progresses through its cell phases, control is exerted at various checkpoints, during which the completion of the previous phase is ensured before the cell progresses to the next. These checkpoints involve various external or internal signals such as growth factors, substrate attachment of cells, and DNA repair activity. Currently known checkpoints are at the G1/S phase transition, the G2/M phase transition, and at the point of exit from mitosis [2] .
Practically every eukaryotic organism uses Ca 2+ as a ubiquitous second messenger inducing cellular events as diverse as allergic reactions, muscle contraction, transmitter release, or gene expression [3] . It comes as no surprise that the resumption and progression of the cell cycle, both mitotic and meiotic, seem to be accompanied by oscillatory changes in cytosolic Ca 2+ [4, 5] . Such Ca 2+ signals are thought to be important in the late G1 phase, shortly before M, during M and during cytokinesis. For example, injection of Ca 2+ chelators into fertilized sea urchin eggs was found to block the progression of the cycle, whereas Ca 2+ ionophores induced its resumption [6, 7] . Intracellular Ca 2+ release triggers nuclear envelope breakdown and chromatin condensation in sea urchin eggs, fibroblasts, and in cultured animal cells [6] [7] [8] [9] [10] . Calcium transients have been characterized dur-ing G1 and mitosis [11] and flow-cytometric studies indicate complex changes of Ca 2+ levels throughout the mitotic division [12] . It is thought that Ca 2+ -dependent proteins translate the Ca 2+ signal into a molecular cascade of cellular responses [1] . Calmodulin, for example, is a Ca 2+ -dependent cofactor that stimulates kinases, phosphatases, and proteases, all of which are important players in cell cycle control. In the example of proteases, the role of the Ca 2+ -dependent enzyme calpain seems to be significant for cycle progression [13] . Several studies have explored the role of downstream calcium binding proteins such as calmodulin, calmodulin kinase II and calcineurin in mammalian cells [11] . The role of calcium and CaMII in re-initiating the meiotic cell cycle at fertilization is well documented [14] and the store-operated calcium current (SOC) in Xenopus oocytes is down-regulated during meiosis due to the activation of CDK1 [15, 16] .
Ca 2+ homeostasis in RBL and Jurkat T cells is well documented [17] . The intricate interplay of several essential contributors determines cellular Ca 2+ levels in these cells. Activation of cell surface receptors by growth factors, cytokines, mitogens, or antigen, induces inositol 1,4,5-trisphosphate (InsP 3 ) production and causes the release of Ca 2+ from InsP 3 -sensitive intracellular Ca 2+ reservoirs [18, 19] . Depleted Ca 2+ stores, in turn, induce the activation of a selective Ca 2+ influx pathway termed calcium releaseactivated calcium current (I CRAC ) [20] . Energy-driven Ca 2+ pumps and transporters restore and maintain physiologically adequate Ca 2+ concentrations in the cytosol. The physiological manifestation of these events lead to a wide range of Ca 2+ signaling patterns that manifest themselves as single Ca 2+ transients, repetitive oscillations, or sustained plateaus. These calcium signaling dynamics have been shown to act on gene expression [21, 22] . I CRAC is important for refilling of intracellular Ca 2+ stores [23] , modification of the spatio-temporal pattern of Ca 2+ signaling [24] , contribution to secretion [25] , and regulation of enzymes like adenylate cyclase [26] .
Given that Ca 2+ influx plays an important role in cell proliferation, it is not surprising that ion channels have been implicated in regulating cell cycle progression. Changes in ion channel expression have been documented in some detail for potassium and chloride channels [27, 28] . The former are thought to be important for setting the membrane potential and the driving force for Ca 2+ influx and both are considered important for volume regulation of growing cells. Cell proliferation is regulated by a chain of events that begins with the interaction of growth factors with receptors located in the plasma membrane [29, 30] . Ultimately, this leads to InsP 3 production, Ca 2+ release and I CRAC activation [17] . The role of Ca 2+ store depletion and I CRAC activation in cell cycle control is unknown. However, IL-2 production and lymphocyte proliferation are completely suppressed by removal of extracellular Ca 2+ [31] or pharmacological block of I CRAC . In addition, primary immunodeficiency, characterized by the inability to stimulate lymphocyte proliferation, has been linked to a genetic defect in I CRAC [32, 33] . Also, the phosphorylation of phosphoinositides by phosphatidylinositol-3-kinase is thought to play a crucial role in controlling cell proliferation [34] . It is tempting to speculate that Ca 2+ release and I CRAC are involved in the process.
TRPM7 is a ubiquitously expressed and constitutively active divalent cation channel, whose basal activity is regulated by intracellular levels of magnesium (Mg 2+ ) and Mg·ATP [35] . The channel permeates both Ca 2+ and Mg 2+ ions, but its ability to permeate Mg 2+ is essential for cell growth and survival [36] . We previously described endogenous TRPM7-like Mg 2+ -nucleotide-regulated metal currents (MagNuM) in RBL-2H3 cells [35, 37] . Their contribution to cell cycle regulation is unknown, although recent data indicate a role of MagNuM in cell cycle progression at the G1/S border of retinoblastoma cells [38] .
Little information is available on the effect of low extracellular Mg 2+ on cell cycle [39] . Early work by Rubin suggested that Ca 2+ and Mg 2+ synergize in cell growth and proliferation [40] . Another group proposed that extracellular Mg 2+ is essential for progression of WI-38 fibroblast from G1 into S phase [41] . This essential role of Mg 2+ during the G1 phase was further strengthened by findings involving cyclins and cyclin-dependent kinases (CDK) [39] . Cyclins are positive regulators of CDKs that govern cell cycle progression in their complexed form. Cyclin-CDKs are under the control of inhibitory proteins belonging to the INK4 or Cip/Kip family. Specifically, the Cip/Kip family protein p27 kip1 inhibits CDKs responsible to push progression from G1 to S phase. Indeed, p27 kip1 is distinctively up-regulated in HL-60 and HC11 mammary epithelial cells grown in Mg 2+ -deficient media [42, 43] supporting the notion that the availability of extracellular Mg 2+ during cell cycle progression is most important during G1.
We have carried out a number of experiments to characterize changes of I CRAC and TRPM7-like MagNuM currents at various stages of the cell cycle in the rat mast cell line RBL-2H3. We performed patch-clamp experiments in the whole-cell configuration and measured DNA content by flowcytometric population analyses. The current work shows that I CRAC and MagNuM are tightly regulated at distinct cell cycle phases.
Methods

Cells
RBL-2H3-M1 cells were grown on glass coverslips with standard DMEM medium supplemented with 10% fetal bovine serum (FBS, Gibco) unless indicated otherwise (see below).
Flow cytometry using propidium iodine (PI) staining
PI staining was performed using established protocols [44] . Briefly, harvested RBL-2H3 cells were re-suspended in a phosphate-buffered saline (PBS)/ethanol mixture (30/70%) and incubated in PBS containing 400 g/ml PI (Sigma) and 1 mg/ml Rnase (Sigma). Samples were analyzed at The Queen's Medical Center Pathology Laboratory using a Coulter EPIC flow cytometer. Between 20,000 and 40,000 cells were analyzed per sample run. Results were gated to exclude doublets. Multicycle AV (Phoenix Flow Systems) was used as acquisition program and FlowJo (Tree Star, Inc.) and Igor Pro (WaveMetrics) were used for data analysis.
Synchronization of RBL-2H3-M1 cells in specific cell cycle phases
Synchronization was performed according to standard methods [45] and fine-tuned to RBL-2H3 cells. All protocols were designed to ensure that cells were both reversibly and almost completely arrested at one defined point in the cell cycle and confirmed by flow cytometry (FACS). The chemicals used to synchronize cells were tested acutely at a concentration of 10 M on fully activated I CRAC to ensure no direct effects (data not shown).
Synchronization in the G0-like and G1 phase using serum-, Ca 2+ -, and isoleucine-deprivation
Exponentially growing cells were trypsinized, centrifuged, washed twice in sterile PBS and re-suspended at 30% of their confluent density (7.25 × 10 4 cells/ml) in medium that either contained 0% FBS, 20 M CaCl 2 (standard medium with 1.348 mM K-Bapta added) or 0 mg/ml isoleucine (MEM Select Amine Kit, Invitrogen). For serum and isoleucine-deprivation cells were analyzed after 24 h by FACS and patch-clamp experiments. Cells that were Ca 2+ deprived (20 M) were analyzed 48 h by FACS and patchclamp experiments.
Synchronization at the G1/S border
Cells were seeded and grown in isoleucine-free medium as described above. After 24 h cells were grown in standard medium with added 5 g/ml aphidicolin (Sigma) for 8 h and analyzed by FACS. Patch-clamp experiments were performed at a maximum of 45 min per cover slip to avoid de-synchronization effects.
Synchronization in the middle of the S phase
Cells were grown in isoleucine-free conditions for 24 h and subsequently in aphidicoline conditions as described above for an additional 24 h. Cells were then released for 2 h in standard medium and growth-arrested using 2 mM thymidine block (Sigma) for 3 h before analysis.
Synchronization in G2
Cells were grown for 38 h in isoleucine-free medium and subsequently maintained in standard medium with 5 g/ml aphidicolin for an additional 10 h. Cells were washed and returned into standard medium containing 500 ng/ml HOECHST 33342 (Sigma) for 8 h.
Synchronization in mitosis
Cells were grown until 60-80% confluency, tapped vigorously and the supernatant removed. The remaining cells were incubated in standard medium that contained 0.05 g/ml nocodazole (Fluka) for 4 h. For patch-clamp experiments, harvested cells were kept in nocodazole containing medium in a 50 ml sterile tube on ice. About 500 l of cells were removed from the tube, spun for 30 s in a picofuge, diluted in 500 l external standard solution and plated on the experimental chamber. Cells were allowed to settle for 2 min before patch-clamping. Each mitotic plate thus prepared was used for a maximum of 45 min. Experiments were timed such that a new mitotic harvest was available after 4 h.
Solutions
Cells grown on glass coverslips were transferred to the recording chamber and kept in a standard modified Ringer's solution of the following composition (in mM): NaCl 140, KCl 2.8, CaCl 2 10, MgCl 2 2, glucose 11, Hepes·NaOH 10, pH 7.2. Intracellular pipette-filling solutions contained (in mM): Cs-glutamate 140, NaCl 8, MgCl 2 1, Cs-BAPTA 10, 20 M IP 3 , 10 HEPES·CsOH, pH 7.2. Solution changes were performed by pressure ejection from a wide-tipped pipette to ascertain that the pharmaceuticals used in the cell cycle synchronization did not have any acute effects on I CRAC .
Patch-clamp experiments
Patch-clamp experiments were performed in the tightseal whole-cell configuration at 21-25 • C. High-resolution current recordings were acquired using the EPC-9 (HEKA). Voltage ramps of 50 ms duration spanning a range of −100 to +100 mV were delivered from a holding potential of 0 mV at a rate of 0.5 Hz over a period of 300-600 s. All voltages were corrected for a liquid junction potential of 10 mV. Currents were filtered at 2.9 kHz and digitized at 100 s intervals. Capacitive currents were determined and corrected before each voltage ramp. Extracting the current amplitude at −80 mV for I CRAC and +80 mV for MagNuM from individual ramp current records assessed the low-resolution temporal development of both currents. Where applicable, statistical errors of averaged data are given as means ± S.E.M. with n determinations. Gaussian, sigmoid and exponential curves were fitted using standard equations. Cell volume was calculated assuming spherical cell shape and a specific membrane capacitance of 1 F/cm 2 [46] .
Results
Continuously dividing cells maintain an exponential growth rate progressing through relatively well-defined stages of the cell cycle. Progression into several of the cycle's phases involves [Ca 2+ ]i signals of various forms, ranging from single spikes due to Ca 2+ release to oscillations in Ca 2+ caused by Ca 2+ release and Ca 2+ influx [47] . The various cell cycle stages and the changes in [Ca 2+ ]i typically observed in oocytes and somatic cells [48] are illustrated schematically in Fig. 1A .
DNA profile, I CRAC current density and cell capacitance of exponentially growing cells
Progression through the cell cycle is correlated with changes in both DNA content and cell capacitance [49] . We assessed these two parameters by flow cytometry (FACS) and patch-clamp measurements in RBL-2H3 cells. When grown under standard tissue culture conditions and populations are split regularly to avoid confluency, these cells maintain an exponential growth rate with a normal distribution between cell cycles (control conditions).
FACS takes advantage of the fact that DNA content doubles from G1 (2n) to M (4n), which is reflected by the emission intensity of propidium iodide (PI) bound to DNA. The results show that 38 ± 1.5% of cells were in G1, 41 ± 1.2% of cells were in the S phase, and 24 ± 2.7% of cells were in G2 or undergoing mitosis (n = 6 ± S.E.M., see Fig. 1B ).
We next performed patch-clamp experiments to determine cell membrane capacitance, which represents a very accurate assessment of cell size, as it is directly correlated to cell surface area [50] . We assessed the capacitance of a large number of RBL-2H3 under control conditions (Fig. 1C) and determined an average value of 15.6 ± 0.31 pF (n = 164). However, the binned frequency distribution of cell capacitance values reveals that the cell size distribution is not uniformly Gaussian. Instead it is skewed, with the majority of cells being in the range of 11-16 pF (62%), about 20% of cells ranging from 17 to 20 pF, and the remaining cells being quite small (7 pF) or quite large (40 pF) . This indicates that the majority of cells around 16 pF or less may reflect the dominant cell cycle stage of G1 and S, whereas the fewer large cells reflect cells in G2 and M phases.
Some of the cells analyzed for cell capacitance were also analyzed for the development of I CRAC during the course of a whole-cell patch-clamp experiment. Using standard conditions, I CRAC was measured in external sodium Ringer containing 10 mM Ca 2+ and 10 mM Cs + to inhibit the inwardrectifier potassium channel. The cells were perfused intracellularly with a Cs-glutamate-based solution containing 10 mM BAPTA to chelate internal Ca 2+ and 20 M InsP 3 to fully release Ca 2+ from intracellular stores. Voltage ramps of 50 ms duration and ranging from −100 to +100 mV were applied every other second. Increases in inward currents were measured at −80 mV and plotted versus time ( Fig. 1D ; n = 42). A typical current-voltage data trace extracted at 100 s of wholecell time is shown in Fig. 1E . The average peak inward current at −80 mV from the whole population was 3.16 ± 0.08 pA/pF (n = 164 ± S.E.M.).
Extracellular Ca 2+ is crucial for cell cycle progression
Extracellular Ca 2+ has long been implicated to play a role in cell cycle progression [47] . However, few studies have in fact investigated the effect of Ca 2+ -deprivation on cell cycle [41, 47, [51] [52] [53] . WI-38 cells reportedly arrest in G1 if the Ca 2+ in the medium falls below 60 M [41] . We assessed the effects of lowering Ca 2+ to 20 M in the cell culture medium on the growth of RBL-2H3 cells and confirmed that under these conditions cells stop growing (Fig. 1F ). FACS data (Fig. 2D , lower panel) indicate that 84 ± 1.7% (n = 3) were in G1, 7% in S and 6% in G2 or mitosis. However, growth arrest under 20 M extracellular Ca 2+ concentrations was somewhat slow and manifested itself after ∼48 h. Lowering extracellular Ca 2+ even further (500 nM) prevented cell growth at start (Fig. 1F) .
To study the properties of RBL cells at various defined cell cycle stages, we employed established protocols for arresting cells in desired phases. The agents in these protocols were selected for arresting cells at a single specific point in the cell cycle and the fact that their cell cycle block is reversible.
Serum withdrawal arrests RBL-2H3 cells in G0
A standard procedure to growth-arrest cells is to deprive them of serum for 24 h (see Section 2). This is thought to produce quiescent cells in G0, as it removes growth factors necessary to stimulate cell growth. In our hands, RBL-2H3 subjected to serum-deprivation indeed reacted with growth arrest as established by cell counting (Fig. 1F) and FACS (Fig. 2D) . On average, 75 ± 9% of serum-deprived cells were arrested in G0 (Fig. 2D, upper panel, n = 3) , with only 9 ± 3.7% in S and 9 ± 2.9% in G2 or mitosis. Another standard method of causing growth arrest is amino aciddeprivation in cycling cells. Omission of the amino acid isoleucine is most limiting to cells in mid-G1, about 4 h from the G1/S boundary [54] . Our results show that RBL-2H3 stopped growing very efficiently (Fig. 1F) with the majority of cells in G1 (90 ± 9%, Fig. 2D , middle panel, n = 2), and only 3 ± 0.2% in S and 4 ± 1.6% in G2 or mitosis.
We next assessed changes in cell size using these three methods for growth arrest. Cell capacitance values of 148 individual serum-deprived cells were pooled, binned, and plotted as a cell capacitance distribution histogram in Fig. 2E . Interestingly, serum-deprived cells had larger cell surfaces than control and had a wide distribution width as confirmed by the histogram plot (Fig. 2E, upper panel) . In contrast, cells deprived of Ca 2+ or isoleucine, were not enlarged and had cell size distributions very similar to control cells ( Further analyses of the growth-arrested cells yielded estimates for activation time course ( Fig. 2A) and peak current amplitudes of I CRAC in individual RBL cells. To assess current densities, currents were normalized to cell capacitance ( Fig. 2C and F) . In general, serum-deprived cells had either no measurable or strongly reduced I CRAC ( Fig. 2A and C) . The more detailed analysis using histogram plots (Fig. 2F) reveals that in serum-deprived conditions, 66 out of 148 cells did not express any discernible I CRAC at all, and the rest had strongly suppressed currents. In contrast, Ca 2+ -or isoleucinedeprivation had less or no effect on peak current densities ( Fig. 2A and C) .
I CRAC increases in preparation for and during chromatin duplication
Inhibiting DNA synthesis using the DNA polymerase blocker aphidicolin reversibly arrests cells at the G1/S transition [45] . RBL-2H3 were first synchronized in G1 using 24-h isoleucin-deprivation and subsequently released into an aphidicolin-containing complete medium for 8 h (see Section 2). This efficiently arrested over 90% of cells at the G1/S transition (92 ± 2; S: 5 ± 1%; G2/M: 1.5 ± 0.4%; n = 4; Fig. 3A ). During G1, cells start to increase in size as they produce proteins in preparation for DNA duplication. Indeed, when analyzing the membrane capacitance of individual cells, it is clear that cell surface at the G1/S border is significantly shifted to the right compared to control ( Fig. 3B ; average cell size = 21 ± 0.4 pF; n = 149). At the same time, I CRAC also is significantly up-regulated, with the peak of the Gaussian distribution clearly shifted to the right ( Fig. 3C; 4.4 ± 0.07 pA/pF; n = 149). Thus, I CRAC is increased by about 40% compared to average values, consistent with the notion that the G1/S checkpoint is dependent on extracellular Ca 2+ [41, 51, 52] . We next set out to arrest the majority of cells in mid-S phase using a combination of isoleucine-deprivation, aphidicolin exposure, release of cells into S phase for 2 h and finally block by thymidine, a DNA synthesis inhibitor (see Section 2). This method reliably arrested 85 ± 2% in mid-S phase (Fig. 3E) , with only 7 ± 0.6% of cells in G1 and 4 ± 1.6% of them in G2 or M (n = 4). The analysis of the cell capacitance and current density histograms (Fig. 3F and G) revealed that both parameters were comparable to the results obtained for the G1/S boundary. Both average cell size remained enlarged (20.5 ± 0.4 pF; n = 154) and I CRAC stayed up-regulated (4 ± 0.09 pA/pF; n = 154). Importantly, the overall current-voltage relationship and time course of activation of I CRAC did not change under these conditions ( Fig. 3D and H) .
To arrest cells in G2, where cells prepare for division, we adapted a well-established protocol that achieves efficient and reversible G2 synchronization using the topoisomerase II inhibitor HOECHST 33342 (see Section 2), rendering 70 ± 2% of cells in G2/M ( Fig. 4A ; G1: 14 ± 2%; S: 11 ± 2.3%; n = 5). As anticipated, cells had the largest cell surface at this stage of the cycle reaching up to 42 pF ( Fig. 4B ; n = 134) with a wide distribution profile. Furthermore, CRAC currents were still up-regulated, although a significant number of cells (29%) started to express normal or even smaller I CRAC (Fig. 4C) . It is important to note that the increase in I CRAC reflects a genuine increase in current density that is not simply due to the change in cell size, since all the data have already been normalized to cell capacitance.
Mitotic RBL-2H3 cells regain normal cell volume but have strongly suppressed I CRAC
We next set out to investigate the profile of cells collected in mitosis. Here, we took advantage of the drug nocodazole (see Section 2), which reversibly arrests cells at metaphase by destabilizing the microtubule structure [45] . Nocodazole synchronization successfully arrested 75 ± 5% of cells in metaphase ( Fig. 4E; n = 3) , with 6 ± 4% residing in G1 and 14 ± 3% of cells processing through S phase. Interestingly, when analyzing the cell capacitance histogram of 175 mitotic cells, it overlapped with the distribution measured in control cells (Fig. 4F) . However, the current density profile for I CRAC could be divided into three groups: 20% of cells expressed no I CRAC at all, 43% had less than 1 pA/pF of current and the third group exhibited a Gaussian distribution peaking around 2.3 pA/pF. Averaging all cells rendered mitotic current densities at 1.25 ± 0.08 pA/pF (n = 175). The I/V relationship of I CRAC (Fig. 4D ) and its activation time course (Fig. 4H) were not affected by the mitotic cell cycle stage.
TRPM7-like MagNuM currents are uncoupled from cell cycle phases except during G1
Although mast cells employ store-operated Ca 2+ influx as a major source for Ca 2+ signaling following receptor stimulation, RBL-2H3 also possess homeostatic currents that regulate Ca 2+ and Mg 2+ transport. These are mediated by TRPM7 channels [35] and native currents that exhibit the TRPM7- ). Current analysis as described in Fig. 2A . specific inhibition by free [Mg 2+ ]i and Mg-nucleotides have been characterized in T cells and RBL-2H3 and termed MagNuM [35, 37] . MagNuM currents activate in RBL-2H3 under the experimental conditions typically used when studying I CRAC [37] and they were also observed in the experiments of the present study as outwardly rectifying currents that develop slowly with a half-maximal current obtained at ∼220 s, presumably due to omission of Mg·ATP from the pipette-filling solution. To gain insight on cell cycle-specific changes in MagNuM activity, we analyzed current records from the same cells analyzed for I CRAC for possible changes in MagNuM current densities. This analysis was performed at +80 mV, where I CRAC does not conduct significant outward currents. Fig. 5A illustrates the average time course and amplitudes of MagNuM currents for cells at the various stages and Fig. 5B shows the average current densities obtained at 250 s into the experiment. These data demonstrate that TRPM7 expression is tightly controlled across the cell cycle close to ∼2 pA/pF of current density, irrespective of changes in cell size that occur. However, in mid-G1, the MagNuM current densities exhibit a near three-fold increase compared to all other stages (Fig. 5B ). This observation is consistent for RBL-2H3 arrested in late G1 in low extracellular Ca 2+ conditions. Here, the increase in current density is about two-fold. While the G1 stage exhibits normal I CRAC densities, the MagNuM increase is dramatic and immediately returns to basal levels in subsequent stages, suggesting that both I CRAC and MagNuM serve specific roles at specific cell cycle checkpoints.
Discussion
Signaling events involving Ca 2+ release and Ca 2+ influx are believed to be important factors in the complex regulation of cell growth and proliferation [47] . The present study underscores this notion in that the reduction of extracellular Ca 2+ concentration indeed prevents RBL-2H3 cells from proliferating. Our results suggest that as these cells progress through the various stages of the cell cycle, they can up-or down-regulate ion channel pathways provided by the store-operated Ca 2+ current I CRAC and by the Mg 2+ -and Mg 2+ -nucleotide-regulated Ca 2+ /Mg 2+ -permeable ion current MagNuM (TRPM7). We find that I CRAC current densities increase from normal levels of ∼3 pA/pF (at −80 mV) in the G1 stage to ∼4.5 pA/pF at the transition of G1/S phase and remain elevated throughout S and G2 phase until they precipitously fall to ∼1 pA/pF during metaphase of mitosis. In contrast, MagNuM has a relatively stable current density of ∼2 pA/pF (at +80 mV) in all stages, except for G1, where it is very high at ∼6 pA/pF. This regulation appears to be specific for each of the pathways and suggests that it may be designed to meet cellular demands for Ca 2+ and/or Mg 2+ fluxes of each cell stage.
We used established protocols to arrest cells at various cell cycle stages. Although most of the protocols involve some pharmacological manipulation, our results do not indicate that the observed effects were pharmacological in nature or unrelated to cell cycle arrest: (1) none of the treatments had any significant effect on I CRAC or MagNuM when 10 M of the individual compounds (aphidicoline, nocodazole, HOECHST 33342) was applied acutely after the currents were activated in control cells; (2) we never saw a concomitant suppression of CRAC and MagNuM currents that would indicate non-specific inhibition of ion channels by the pharmacological treatments or non-specific up-or downregulation of ion channels in general; (3) we did not observe erratic up-or down-regulation of I CRAC or MagNuM between adjacent cell cycle stages; (4) the amplitude distribution of I CRAC in untreated, normally cycling cells is in excellent agreement with both the average amplitudes of cells arrested at individual cell cycle stages and their relative proportion within the mixed population of untreated cells.
While most of the treatments arrested ∼90% of the cells in the desired cell cycle stage, the arrest in G2 was somewhat less effective, resulting in 70% of cells in G2 and ∼15% in G1. Since the population of cells was not as uniform as in the other stages, the presence of a small population of cells in G1, which typically exhibit smaller cell surfaces and I CRAC , may result in a slight underestimate of the G2-specific values. Nevertheless, we consider the data obtained for this stage as informative, since the average cell size was still largest compared to all other stages and I CRAC amplitudes were still elevated. A similar non-uniform arrest of cells may affect the quantification of I CRAC at mitosis. Based on FACS, we estimate that ∼75% of cells were in the mitotic stage and the rest in various stages leading up to it. The electrophysiology revealed contributions from two populations: one that had either no or very small I CRAC below 1 pA/pF and a second population with amplitudes of ∼2 pA/pF, which may be due to the cells approaching but not yet arrested in metaphase. By averaging the current amplitudes of both populations, we may be slightly overestimating the true I CRAC amplitude during mitosis itself and cells may in fact completely down-regulate I CRAC during a narrow time frame within that stage.
The mitotic stage reveals another interesting phenomenon in that cells appear to have returned to normal capacitance of ∼15 pF as seen in G1, i.e., cell membrane capacitance is ∼50% of the cell surface achieved in G2, as if the cells had already divided. However, nocodazole arrests cells in metaphase by interfering with mitotic spindle formation, and would therefore rule out cell division as the reason for the capacitance decrease. It is thought that microtubules are essential in orchestrating the initiation of membrane retrieval in preparation for cytokinesis [55] . However, the whole-cell patch-clamp technique is the most sensitive approach todate to measure minute changes in cells surface. Hence, this method may provide the ability to detect membrane retrieval at much earlier times than conventional fluorescent methods. Therefore, our data may indicate that a reduction in cell surface due to membrane retrieval in preparation for cell division may indeed start earlier in mitosis than previously assumed [55] . Such membrane retrieval may also engulf membrane proteins and could in part account for the reduction in I CRAC we observe at this cell cycle stage. However, we do not see a significant decrease in the current density of MagNuM, suggesting that the process is not indiscriminate, but may involve specific membrane areas, possibly lipid rafts, that might predominantly harbor CRAC channels [56] . The overall reduction of I CRAC and relative low abundance of MagNuM in mitotic cells indicates that Ca 2+ influx plays a minor role during mitosis. This is in agreement with the observation that changes in intracellular Ca 2+ levels during mitosis are predominantly due to InsP 3 -induced Ca 2+ release but not influx [13, 19, 57] .
Another important aspect to consider is that the volume of the cell changes as well. Fig. 6 illustrates the cell cycledependent changes of both the cell surface as assessed by membrane capacitance and the corresponding cell volume, which was calculated assuming spherical shape of cells, a smooth unfolded cell surface and specific capacitance of 1 F/cm 2 [46] . In terms of surface to volume ratio, this would mean that an x-fold increase in surface leads to an x 1.5 -fold increase in volume. In both cases, the values of these parameters were normalized to those obtained at the isoleucine-induced G1 stage. As can be seen in Fig. 6A , the change in cell volume is even more dramatic than the change in surface area. Fig. 6B and C summarize the relative changes in I CRAC and MagNuM as a function of cell surface and volume, respectively. This reveals that while the current density of I CRAC is increased during S and G2 phases, it remains relatively constant when plotted against cell volume. This has functional consequences for store-operated Ca 2+ influx in that the up-regulated I CRAC will maintain its efficacy in providing the cytosol with relatively constant amounts of Ca 2+ to change global [Ca 2+ ]i, however, the larger current densities will be more effective in regulating Ca 2+ -dependent processes underneath the plasma membrane, in particular Ca 2+ -dependent exocytosis, which represents a crucial physiological response of mast cells. During mitosis, I CRAC is strongly down-regulated, suggesting that this process does not require significant contributions from storeoperated mechanisms.
Our data also reveal an interesting regulation of I CRAC by serum factors in that serum removal causes growth arrest in G0 and a massive down-regulation of I CRAC . A previous study attributed this loss of I CRAC to cell cycle arrest [58] . However, our data argue against a cell cycle-specific effect of serum-deprivation, since arresting cells at a similar, but proliferatively active stage does not cause I CRAC reduction (Figs. 2 and 5C ). Therefore, serum-deprivation appears to regulate I CRAC independently of cell cycle stage, possibly through signal transduction mechanisms that control transcription factors needed for I CRAC expression.
In contrast to I CRAC , MagNuM is largest in G1 and is strongly down-regulated during cell growth, suggesting that its function as a Ca 2+ and Mg 2+ influx pathway is primarily needed during G1. It is presently unknown whether the function of MagNuM is based on its basal activity and simply provides a constant influx of Ca 2+ and Mg 2+ to maintain cellular homeostasis of these ions [35] or its activity is regulated by receptor signaling, as has been shown to be the case [59] . Although TRPM7/MagNuM have been clearly implicated in the regulation of cell growth [35, 36, 38] , it remains to be determined what the relative roles of Ca 2+ and Mg 2+ transport through MagNuM are. We have previously demonstrated that supplementation of extracellular Mg 2+ , but not Ca 2+ , can restore cell growth in DT40 B cells in which TRPM7 has been knocked out [36] , suggesting that Mg 2+ transport is a crucial component of TRPM7 in supporting cell growth. On the other hand, Hanano et al. [38] have reported that the Ca 2+ transport function of this channel may be important in regulating cell growth in retinoblastoma cells.
This effect may primarily influence the rate of proliferation, since siRNA-mediated knock down of TRPM7 delays the transition of cells from G1 into S phase. Furthermore, reports by Hazelton et al. [41] and work from Cittadini's group [42, 43] emphasize the importance of extracellular Mg 2+ specifically during G1 phase progression. Based on these and our data it is tempting to speculate that MagNuM, as a Ca 2+ -and Mg 2+ -permeable influx pathway, indeed provides these ions in a homeostatic fashion throughout G1, rendering the progression through this cell cycle stage largely independent of store-operated Ca 2+ influx mediated by I CRAC .
In summary, our data suggest that the two primary influx pathways for Ca 2+ , I CRAC and MagNuM, are regulated in characteristic manner as cells initiate proliferation. We determined that Ca 2+ ions are a crucial component in driving cell proliferation, since Ca 2+ -deprivation arrests cells in the G1 stage. The fact that this procedure traps cells in that particular stage would also suggest that Ca 2+ influx is particularly important during that period of the cell cycle. Since MagNuM is up-regulated in that stage, we surmise that it might be an important factor in driving cell proliferation during G1. The down-regulation of MagNuM and the parallel upregulation of I CRAC in subsequent stages may reflect a shift in the requirements for Ca 2+ influx, where the increased cell volume requires more effective store-dependent Ca 2+ influx.
